Applying Peptide Mapping and Multi- Attribute Method (MAM) Workflow for Biosimilar mAb Drug Products Comparison on the Xevo™ G3 QTof Platform

Applications | 2022 | WatersInstrumentation

LC/TOF, LC/HRMS, LC/MS, LC/MS/MS

Industries

Pharma & Biopharma, Proteomics

Manufacturer

Waters

Go to the library View PDF

Downloadable PDF for viewing

Similar PDF

PEPTIDE CHARACTERIZATION AND MONITORING WORKFLOW FOR BIOSIMILAR mAb DRUG PRODUCTS USING A COMPLIANCE READY LC-MS AND INFORMATICS PLATFORM

2023|Waters|Posters

PEPTIDE CHARACTERIZATION AND MONITORING WORKFLOW FOR BIOSIMILAR mAb DRUG PRODUCTS USING A COMPLIANCE READY LC-MS AND INFORMATICS PLATFORM 20221115_Remicade T0_200ng_03 2 TOF MSe (50 2000) 6V ESI (BPI) 1/2 20221115_Inflectra T0_200ng_12 2 TOF MSe (50 2000) 6V ESI (BPI) Kellen…

Key words

biosimilar, peptide, inflectra, mam, attributes, remicade, monitoring, innovator, ang, avsola, app, renflexis, attribute, informatics, error

Multi-Attribute Methods for Biopharmaceutical Analysis

2022|Waters|Guides

[ APPLICATION NOTEBOOK ] Multi-Attribute Methods for Biopharmaceutical Analysis Application Notes [ APPLICATION NOTEBOOK ] Introduction The adoption of LC-MS-based multi-attribute method (MAM) analysis for routine monitoring of biotherapeutic variation has progressed greatly over the last five years. The ability…